References
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939–51.
- Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010;65:1807–18.
- Paterson DL. Impact of antibiotic resistance in Gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 2008;47(Suppl 1):S14–20.
- Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2000;29(Suppl 4): 64–8.
- Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart PR, Bheemreddy S, et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol 2011;32:861–71.
- Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, et al “Swimming in resistance”: co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control 2012;40:830–5.
- Mammina C, Bonura C, Aleo A, Calà C, Caputo G, Cataldo MC, et al. Characterization of Acinetobacter baumannii from intensive care units and home care patients in Palermo, Italy. Clin Microbiol Infect 2011;17:E12–5.
- Mammina C, Bonura C, Di Bernardo F, Aleo A, Fasciana T, Sodano C, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill2012;17. pii: 20248.
- Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–32.
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints v.2.0. EUCAST; 2012. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf (accessed 26 February 2013).
- Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351–3.
- Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028–33.
- Arvaniti K, Lathyris D, Ruimy R, Haidich AB, Koulourida V, Nikolaidis P, et al. The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Crit Care 2012;16:R102.
- Centers for Disease Control and Prevention (CDC). Guidance for control of infection with carbapenem-resistant or carbapenemase producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep 2009;58:256–60.
- Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30:447–52.
- Snyder GM, O’Fallon E, D’Agata EM. Co-colonization with multiple different species of multidrug-resistant Gram-negative bacteria. Am J Infect Control 2011;39:506–10.